Inventor · disambiguated record
Richard B. Sulsky
Also filed as: SULSKY RICHARD · SULSKY RICHARD B
45 granted patents·4 pending applications·2,462 citations·filing 1987–2012
98Inventor score
Top patents by PatentIndex Score
49 records- 0199US6395767B2Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted May 28, 2002·398 cites·24 claims
- 0299US5760246AConformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and methodFiled 1996·Granted Jun 2, 1998·304 cites·10 claims
- 0399US5712279AInhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Jan 27, 1998·319 cites·19 claims
- 0498US6548529B1Heterocyclic containing biphenyl aP2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Apr 15, 2003·273 cites·27 claims
- 0598US5739135AInhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Apr 14, 1998·297 cites·38 claims
- 0698US5712396Aα-phosphonosulfonate squalene synthetase inhibitorsFiled 1994·Granted Jan 27, 1998·196 cites·26 claims
- 0797US6573287B22,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jun 3, 2003·112 cites·9 claims
- 0897US4820828ACinnamohydroxamic acidsORTHO PHARMA CORP·Filed 1987·Granted Apr 11, 1989·78 cites·2 claims
- 0994US5962440ACyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Oct 5, 1999·173 cites·15 claims
- 1092US8557841B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesYU GUIXUE·Filed 2012·Granted Oct 15, 2013·17 cites·1 claims
- 1191US7884113B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 8, 2011·8 cites·8 claims
- 1291US7417028B2Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·20 cites·22 claims
- 1390US8119808B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsSUN CHONGQING·Filed 2011·Granted Feb 21, 2012·8 cites·9 claims
- 1489US6472414B1Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Oct 29, 2002·42 cites·12 claims
- 1588US5066658ASubstituted hydroxyureasORTHO PHARMA CORP·Filed 1990·Granted Nov 19, 1991·35 cites·10 claims
- 1686US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 1784US6670380B2Pyridone inhibitors of fatty acid binding protein and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 30, 2003·20 cites·14 claims
- 1883US8143425B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesEWING WILLIAM R·Filed 2005·Granted Mar 27, 2012·5 cites·11 claims
- 1981US7166596B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 23, 2007·9 cites·12 claims
- 2081US6919323B2Pyridazinone inhibitors of fatty acid binding protein and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 19, 2005·10 cites·9 claims
- 2180US7910601B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Mar 22, 2011·2 cites·2 claims
- 2278US5883099AInhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Mar 16, 1999·29 cites·9 claims
- 2377US7960349B2N-terminally modified GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 14, 2011·2 cites·18 claims
- 2476US7220859B2Bicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 22, 2007·1 cites·8 claims
- 2576US6984645B2Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding proteinBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 10, 2006·8 cites·14 claims
- 2675US7276608B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 2, 2007·6 cites·4 claims
- 2775US6649622B2Tetrahydropyrimidone inhibitors of fatty acid binding protein and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 18, 2003·8 cites·11 claims
- 2875US6066650AInhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1997·Granted May 23, 2000·26 cites·2 claims
- 2975US5470845AMethods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemiaBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Nov 28, 1995·14 cites·14 claims
- 3072US8030306B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 4, 2011·1 cites·13 claims
- 3171US7799801B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Sep 21, 2010·0 cites·2 claims
- 3271US7572808B2Triazolopyridine cannabinoid receptor 1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 11, 2009·1 cites·13 claims
- 3371US4904667A1H-1,2,4-thiadiazolo(3,4-b)quinazolin-5-one-2,2-dioxides, and a method for increasing the cardiac output of a mammal with themORTHO PHARMA CORP·Filed 1989·Granted Feb 27, 1990·9 cites·11 claims
- 3468USRE44186ECyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and methodROBL JEFFREY A·Filed 2011·Granted Apr 30, 2013·1 cites·43 claims
- 3562US5464865A4-aryl- and 4-arylthio-5-hydroxy-2(5H)-furanones as inhibitors of phospholipase A2ORTHO PHARMA CORP·Filed 1993·Granted Nov 7, 1995·7 cites·18 claims
- 3661US7592354B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 22, 2009·0 cites·2 claims
- 3761US7589102B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 15, 2009·0 cites·16 claims
- 3858US8232291B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesYU GUIXUE·Filed 2011·Granted Jul 31, 2012·0 cites·2 claims
- 3958US7977353B2Heterocyclic aromatic compounds useful as growth hormone secretagoguesBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jul 12, 2011·0 cites·6 claims
- 4056US2008242593A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 4152US5103036AProcess for preparing 3-alkenylidene-1,1-bisphosphonatesSQUIBB & SONS INC·Filed 1991·Granted Apr 7, 1992·5 cites·17 claims
- 4251US8614332B2Substituted pyrazolylamides useful as glucokinase activatorsRYONO DENIS E·Filed 2012·Granted Dec 24, 2013·0 cites·18 claims
- 4351US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 4448US8153677B2Substituted pyrazolylamide compounds useful as glucokinase activatorsRYONO DENIS E·Filed 2011·Granted Apr 10, 2012·0 cites·17 claims
- 4547US5567841Aα-phosphonosulfonate squalene synthetase inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Oct 22, 1996·7 cites·11 claims
- 4646US5712261AMethod for preventing or treating hypertriglyceridemiaFiled 1995·Granted Jan 27, 1998·3 cites·18 claims
- 4745US2007238669A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 4843US6034098AInhibitors of microsomal triglyceride transfer protein and methodBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Mar 7, 2000·3 cites·17 claims
- 4941US2007021346A1N-terminally modified GLP-1 receptor modulatorsEWING WILLIAM R·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →